Aldosterone Acutely Stimulates NCC Activity Via a SPAK-mediated Pathway
Overview
Physiology
Authors
Affiliations
Hypertension is a leading cause of morbidity and mortality worldwide, and disordered sodium balance has long been implicated in its pathogenesis. Aldosterone is perhaps the key regulator of sodium balance and thus blood pressure. The sodium chloride cotransporter (NCC) in the distal convoluted tubule of the kidney is a major site of sodium reabsorption and plays a key role in blood pressure regulation. Chronic exposure to aldosterone increases NCC protein expression and function. However, more acute effects of aldosterone on NCC are unknown. In our salt-abundant modern society where chronic salt deprivation is rare, understanding the acute effects of aldosterone is critical. Here, we examined the acute effects (12-36 h) of aldosterone on NCC in the rodent kidney and in a mouse distal convoluted tubule cell line. Studies demonstrated that aldosterone acutely stimulated NCC activity and phosphorylation without affecting total NCC abundance or surface expression. This effect was dependent upon the presence of the mineralocorticoid receptor and serum- and glucocorticoid-regulated kinase 1 (SGK1). Furthermore, STE20/SPS-1-related proline/alanine-rich kinase (SPAK) phosphorylation also increased, and gene silencing of SPAK eliminated the effect of aldosterone on NCC activity. Aldosterone administration via a minipump in adrenalectomized rodents confirmed an increase in NCC phosphorylation without a change in NCC total protein. These data indicate that acute aldosterone-induced SPAK-dependent phosphorylation of NCC increases individual transporter activity.
Potassium-Switch Signaling Pathway Dictates Acute Blood Pressure Response to Dietary Potassium.
Welling P, Little R, Al-Qusairi L, Delpire E, Ellison D, Fenton R Hypertension. 2024; 81(5):1044-1054.
PMID: 38465625 PMC: 11023808. DOI: 10.1161/HYPERTENSIONAHA.123.22546.
Rioux A, Nsimba-Batomene T, Slimani S, Bergeron N, Gravel M, Schreiber S Physiol Rev. 2024; 104(3):1147-1204.
PMID: 38329422 PMC: 11381001. DOI: 10.1152/physrev.00027.2023.
Figueroa S, Bertocchio J, Nakamura T, El-Moghrabi S, Jaisser F, Amador C Pharmaceutics. 2023; 15(5).
PMID: 37242615 PMC: 10223994. DOI: 10.3390/pharmaceutics15051373.
Aldosterone: Renal Action and Physiological Effects.
Johnston J, Welch A, Cain B, Sayeski P, Gumz M, Wingo C Compr Physiol. 2023; 13(2):4409-4491.
PMID: 36994769 PMC: 11472823. DOI: 10.1002/cphy.c190043.
Johnston J, Wingo C Kidney360. 2022; 3(11):1823-1828.
PMID: 36514400 PMC: 9717643. DOI: 10.34067/KID.0005752022.